Condition

CIPN

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 2 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting1

Common interventions3

Lead sponsors shown2

Clinical trials

2 shown

Multimodal Assessment of Cryotherapy for Paclitaxel-Induced NeuropathyNCT07780955 · 2025-10-11

RECRUITING

Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer SurvivorsNCT06711978 · 2024-12-01

COMPLETED

Common interventions

CryotherapyDEVICE1 DuloxetineDRUG1 MirogabalinDRUG1

Leading sponsors

Azienda Sanitaria dell'Alto Adige 1 Pusan National University Yangsan Hospital 1

Trial status mix

COMPLETED1

RECRUITING1

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.